Výsledky vyhledávání - "Kimberly, Hoffman"

Akademický článek

Community Case Study: The Role of Live-Interactive Learning Network in Addressing Community Wide Information Needs Through Show-Me COVID-19 ECHO

Autor: Mirna Becevic, Melissa Warne-Griggs, Emmanuelle Wallach, Karen Edison, Rachel Mutrux, Jane A. McElroy, Albert Hsu, Chi-Ren Shyu, Robin Trotman, Kimberly Hoffman

Publikováno v: Frontiers in Public Health, Vol 10 (2022)

After the COVID-19 pandemic reached Missouri, the Show-Me ECHO (Extension for Community Healthcare Outcomes) project initiated COVID-19 ECHO virtual knowledge-sharing networking sessions. These live-interactive weekly sessions inform participants abo

Externí odkaz: https://doaj.org/article/c6e5a421fa2941c8a172c9f562c684e2

Zobrazit plný text záznamu

Akademický článek

ECHO Autism: Evaluation of Participants’ Perceptions of Collaborative Telementoring Network

Autor: Mirna Becevic PhD, FAMIA, Pooja Nair BS, Emmanuelle Wallach MS, MHA, Kimberly Hoffman PhD, Kristin Sohl MD, FAAP

Publikováno v: Journal of Patient Experience, Vol 8 (2021)

Introduction: Primary care clinicians report inadequate training and lack of support regarding identification of early signs of Autism Spectrum Disorder (ASD), resulting in later diagnosis and poor outcomes. The objective of this study was to evaluat

Externí odkaz: https://doaj.org/article/b37b037713b64a1a828b0947950ea5cd

Zobrazit plný text záznamu

Akademický článek

Library Pedagogies: Personal reflections from library practitioners

Autor: Kimberly Hoffman

Publikováno v: Journal of Learning Development in Higher Education, Iss 21 (2021)

This is a book where European and American academic librarians discuss their journeys of becoming teachers. Many did not pursue librarianship to engage in teaching but found themselves in roles that required instruction, despite a lack of preparation

Externí odkaz: https://doaj.org/article/91976c32056049d7802e5262687a93c4

Zobrazit plný text záznamu

Integrating the Lived Experience Conditions and Care in the ECHO Model

Autor: Tracy, Greever-Rice, Lea, Brandt, Melissa, Warne-Griggs, Kimberly, Hoffman

Publikováno v: Mo Med

Show Me ECHO has introduced a ‘lived experience’ role by including patients and caregivers into some of its ECHO Hub Teams. Grounded in the patient-centered care model, this role provides insights into the lived experience of patients and caregiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::427a47447f3dc1d77607c1f221ca0c22
https://pubmed.ncbi.nlm.nih.gov/32636557

Zobrazit plný text záznamu

Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using Single Photon Emission Computed Tomography-Computed Tomography (SPECT-CT) imaging

Autor: Julia D. Maltzman, Stephen Adler, Ira Pastan, Bruce A. Wallin, Raffit Hassan, Chang Hum Paik, Peter L. Choyke, Kimberly Hoffman, Anish Thomas, Esther Mena, Karen A. Kurdziel, Liza Lindenberg

Publikováno v: Oncotarget
Scopus-Elsevier

// Liza Lindenberg 1, * , Anish Thomas 2, * , Stephen Adler 3 , Esther Mena 4 , Karen Kurdziel 1 , Julia Maltzman 5 , Bruce Wallin 5 , Kimberly Hoffman 5 , Ira Pastan 6 , Chang Hum Paik 7 , Peter Choyke 1 , Raffit Hassan 2 1 Molecular Imaging Program

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c06dabc8111a5f7eb0028587b3842b9a
https://doi.org/10.18632/oncotarget.2883

Zobrazit plný text záznamu

Abstract CT014: Initial results from the Phase I study of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors

Autor: David M. Hyman, Patricia Giblin, Irene Brana, Lillian L. Siu, Nehal Lakhani, Robert Wasserman, Robin M. Hallett, Joan Seoane, Erkut Borazanci, Alison M. Schram, Anna Spreafico, Adrianne Kelly, Daniel D. Von Hoff, Kimberly Hoffman, Josep Tabernero, Judit Anido, Elena Garralda, Naimish Pandya, Marc Oliva

Publikováno v: Cancer Research. 79:CT014-CT014

Background: Leukemia Inhibitory Factor (LIF) is a pleiotropic cytokine involved in many physiological and pathological processes. LIF is highly expressed in a subset of tumors across multiple solid tumor types and has been shown to correlate with poo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fe0c1dc5e2273c1d1d746284945ccef3
https://doi.org/10.1158/1538-7445.am2019-ct014

Zobrazit plný text záznamu

Abstract 1751: MSC-1 is a first-in-class humanized monoclonal antibody that modulates the tumor microenvironment by inhibiting a novel cancer immunotherapy target, LIF

Autor: Monica Pascual, Naimish Pandya, Joan Seoane, Kimberly Hoffman, Robin M. Hallett, Ada Sala, Angus M. Sinclair, Judit Anido, Vanessa Chiganças, Robert Wasserman, Patricia Giblin, Isabel Huber-Ruano, Johan E. S. Fransson, Jeanne Magram, Swetha Raman, Jean-Philippe Julien

Publikováno v: Cancer Research. 78:1751-1751

Leukemia Inhibitory Factor (LIF) is a member of the IL-6 family of cytokines and is involved in many physiological and pathological processes including the promotion of an immunosuppressive environment to support embryo implantation, down-regulation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b7db4780660e351b0d896ee08db7ab6c
https://doi.org/10.1158/1538-7445.am2018-1751

Zobrazit plný text záznamu

A phase 1 study of MSC-1, a humanized anti-LIF monoclonal antibody, in patients with advanced solid tumors

Autor: Patricia Giblin, Judit Anido, Lillian L. Siu, Anna Spreafico, Jeanne Magram, Robert Wasserman, Alison M. Schram, José Baselga, Irene Brana, David M. Hyman, Robin Hallet, Joan Seoane, Isabel Huber Ruano, Kimberly Hoffman, Josep Tabernero, Naimish Pandya

Publikováno v: Journal of Clinical Oncology. 36:TPS2602-TPS2602

TPS2602Background: Leukemia Inhibitory Factor (LIF) is a pleiotropic cytokine involved in many physiological and pathological processes. LIF is highly expressed in a subset of tumors across multipl...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d6f2498b8124482115efd1c080bb3fad
https://doi.org/10.1200/jco.2018.36.15_suppl.tps2602

Zobrazit plný text záznamu

Abstract LB-B34: LIF as a novel cancer immunotherapy target: modulating the tumor microenvironment with MSC-1, a humanized anti-LIF monoclonal antibody

Autor: Angus M. Sinclair, Jeanne Magram, Ada Sala, Kimberly Hoffman, Robert Wasserman, Robin M. Hallett, Judit Anido, Joan Seoane, Naimish Pandya, Monica Pascual, Vanessa Chiganças, Isabel Huber Ruano, Patricia Giblin

Publikováno v: Molecular Cancer Therapeutics. 17:LB-B34

Leukemia Inhibitory Factor (LIF) is a pleiotropic cytokine involved in many physiological and pathological processes. LIF is highly expressed in a subset of tumors across multiple tumor types and has been shown to correlate with poor prognosis. LIF i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::043ef42ed2f35c065a68d3468f5271fb
https://doi.org/10.1158/1535-7163.targ-17-lb-b34

Zobrazit plný text záznamu

A randomized, placebo-controlled study of amatuximab in combination with pemetrexed and cisplatin (P/C) as front-line therapy for subjects with malignant pleural mesothelioma (MPM)

Autor: Dean A. Fennell, Silvia Novello, Arnaud Scherpereel, Bruce A. Wallin, Joachim von Pawel, Anna K. Nowak, Megan McLaughlin, Raffit Hassan, Kimberly Hoffman

Publikováno v: Journal of Clinical Oncology. 34:TPS8577-TPS8577

TPS8577Background: Mesothelin is highly expressed in epithelioid mesothelioma. Amatuximab is a chimeric monoclonal antibody that binds to mesothelin. Amatuximab was studied in a Phase II trial in M...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::342dd9631eeff2d14218f2059c6834ca
https://doi.org/10.1200/jco.2016.34.15_suppl.tps8577

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání